- Report
- August 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- April 2024
- 30 Pages
Global
From €2824EUR$3,250USD£2,462GBP
- Report
- December 2024
- 85 Pages
Spain
From €3041EUR$3,500USD£2,651GBP
- Report
- October 2023
- 133 Pages
Europe
From €3476EUR$4,000USD£3,030GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4128EUR$4,750USD£3,598GBP
- Report
- July 2024
- 70 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- July 2024
- 70 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- February 2024
- 150 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- February 2024
- 181 Pages
Europe
From €4128EUR$4,750USD£3,598GBP
- Report
- February 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- February 2024
- 143 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- February 2024
- 85 Pages
North America
From €4128EUR$4,750USD£3,598GBP
- Report
- August 2023
- 90 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- August 2023
- 150 Pages
North America
From €4128EUR$4,750USD£3,598GBP
- Report
- April 2023
- 110 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- July 2024
- 138 Pages
Japan
From €3475EUR$3,999USD£3,029GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €3475EUR$3,999USD£3,029GBP
- Report
- July 2024
- 139 Pages
United States
From €3475EUR$3,999USD£3,029GBP
- Report
- July 2024
- 134 Pages
Germany
From €3475EUR$3,999USD£3,029GBP
- Report
- July 2024
- 133 Pages
Russia
From €3475EUR$3,999USD£3,029GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more